Whereas individual compound monographs focus on a single CAS registry entry, our comparative technical guides evaluate structural homology, orthogonal receptor signaling cascades, and chromatographic separation requirements across entire peptide families—including GHRH/GHS-R1a dual-receptor dynamics, telomerase/mitochondrial longevity axes, cyclic vs. linear melanocortin ligands, BDNF/TrkB neuroactive heptapeptides, and multi-ligand co-lyophilized blends.
Examines the biochemical basis of orthogonal receptor co-activation in preclinical models (GHRH-R + GHS-R1a; FAK-paxillin + G-actin sequestration) and how RP-HPLC/LC-MS resolves multi-component vials such as CJC-1295/Ipamorelin.
Contrasts 29- to 44-residue GHRH analogs (CJC-1295, Sermorelin, Tesamorelin) with pentapeptide/hexapeptide ghrelin receptor agonists (Ipamorelin, GHRP-2, GHRP-6, Hexarelin) and non-GHR lipolytic fragments (AOD-9604).
Cross-pathway synthesis comparing nuclear chromatin tetrapeptides (Epithalon, Cortagen, Pinealon), mitochondrial rRNA open reading frames (MOTS-c, Humanin), NAD+ sirtuin cosubstrates, and thymic immunomodulators.
Compares linear tridecapeptide alpha-MSH analogs (Melanotan-1 / Afamelanotide), side-chain lactam-cyclized heptapeptides (Melanotan 2, PT-141), and MC1R-sparing anti-inflammatory C-terminal tripeptides (KPV).
Evaluates Pro-Gly-Pro stabilized ACTH(4–7) and tuftsin heptapeptides (Semax, Selank), CNTF adamantylglycine tetrapeptides (P21), HGF/c-Met mimetics (Dihexa), and circadian nonapeptides (DSIP).
Documents Aib8 DPP-4 stabilization, orthogonal Lys26/Lys20 fatty-diacid albumin tethering, biased cAMP vs. beta-arrestin signaling, and SEC-HPLC oligomer verification for acylated incretins.